Carlo De la Sancha

Carlo De la Sancha

Auto-generated profile, based on publicly available information

Carlo De la Sancha

Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis Indiana USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
ZHZhi Huang
Zhi Huang
WSWei Shao
Wei Shao
ZHZhi Han
Zhi Han
AAAhmad Mahmoud Alkashash
Ahmad Mahmoud Alkashash
CSCarlo De la Sancha
Carlo De la Sancha
ZLZaibo Li
Zaibo Li
Advances in computational algorithms and tools have made the prediction of cancer patient outcomes using computational pathology feasible. However, predicting clinical outcomes from pre-treatment histopathologic images remains a challenging task, limited by the poor understanding of tumor immune micro-environments. In this study, an automatic, accurate, comprehensive, interpretable, and reproducible whole slide image (WSI) feature extraction pipeline known as, IMage-based Pathological REgistration and Segmentation Statistics (IMPRESS), is described. We used both H&E and multiplex IHC (PD-L1, CD8+, and CD163+) images, investigated whether artificial intelligence (AI)-based algorithms using automatic feature extraction methods can predict neoadjuvant chemotherapy (NAC) outcomes in HER2-positive (HER2+) and triple-negative breast cancer (TNBC) patients. Features are derived from tumor immune micro-environment and clinical data and used to train machine learning models to accurately predict the response to NAC in breast cancer patients (HER2+ AUC = 0.8975; TNBC AUC = 0.7674). The results demonstrate that this method outperforms the results trained from features that were manually generated by pathologists. The developed image features and algorithms were further externally validated by independent cohorts, yielding encouraging results, especially for the HER2+ subtype.

1 July 2021 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
CSCarlo De la Sancha
Carlo De la Sancha
SKShahbaz Khan
Shahbaz Khan
FAFatimah Alruwaii
Fatimah Alruwaii
HCHarvey Cramer
Harvey Cramer
RSRomil Saxena
Romil Saxena

14 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Jaffar KhanJaffar Khan
Jaffar Khan
CSCarlo De la Sancha
Carlo De la Sancha
MSMohammed Saad
Mohammed Saad
AAAhmad M Alkashash
Ahmad M Alkashash
Asad UllahAsad Ullah
Asad Ullah
HWHoward H. Wu
Howard H. Wu
(1) Background: Although the specificity of brush cytology for the detection of malignant pancreaticobiliary strictures is high, its sensitivity is low. Fluorescence in situ hybridization (FISH) can be used to detect chromosomal aneuploidy in biliary brushing specimens, and when used as an adjunct to routine cytology, it significantly improves diagnostic sensitivity. (2) Methods: We searched our laboratory information system to identify all bile duct brush cytology cases with follow-up surgical pathology between January 2001 and September 2019. Cytologic diagnoses were classified as negative, atypical, suspicious, or malignant. Correlated surgical pathological diagnoses were classified as benign or malignant. FISH test results were obtained for a subset of cytology cases with concurrent FISH testing, and the sensitivity, specificity, positive predictive value, and negative predictive value in identifying malignancy for cytology alone, FISH alone, and combined cytology and FISH were calculated. (3) Results: A total of 1017 brushing cytology cases with histologic correlation were identified. A total of 193 FISH tests were performed concurrently with cytological specimens. Malignant diagnoses were identified in 623 of 1017 patients, while 394 patients had benign strictures. The sensitivity, specificity, positive predictive, and negative predictive rate were 65%, 78%, 83%, and 49% for cytology alone; 72%, 67%, 63%, and 68% for FISH alone; and 85%, 42%, 60%, and 74% for combined cytology and FISH, respectively. Among FISH-positive cases, the risk of malignancy for polysomy was 82% and 32% for trisomy. (4) Conclusions: FISH improves the sensitivity and negative predictive rate of bile duct brush cytology. The combination of cytology and FISH has increased the sensitivity from 65% to 85% and the negative predictive rate from 49% to 74% when compared to cytology alone. A patient with a polysomy FISH result had a significantly higher risk of malignancy than a patient with a trisomy 7 result (82% vs. 32%, p < 0.00001).

2 July 2023 in Journal of Cutaneous Pathology
Verified
Journal Article
Open access
CSCarlo De la Sancha
Carlo De la Sancha
MKMatthew Kuhar
Matthew Kuhar
AKAdele Kraft
Adele Kraft
AAAhmed Alomari
Ahmed Alomari
Mucoepidermoid carcinoma is a malignant neoplasm of exocrine glands that arises predominantly in salivary glands. It is seldom encountered as a primary cutaneous neoplasm, and in those patients, it often involves the external auditory canal. Given their rarity, they can pose a diagnostic challenge and prompt extensive workup. In salivary glands, mucoepidermoid carcinomas commonly harbor CRTC1/3::MAML2 fusions; however, genetic alterations of primary cutaneous neoplasms are less characterized, with previous studies reporting CRTC1 rearrangements in the absence of MAML2 aberrations. Herein, we report a case of a primary cutaneous mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 rearrangement. We also review the clinical, morphologic, and molecular features of this neoplasm and compare them to those reported in the literature and to histopathologic mimics.

22 March 2021 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
CSCarlo De la Sancha
Carlo De la Sancha
RRRoberto Ruiz-Cordero
Roberto Ruiz-Cordero
NPNikolay Popnikolov
Nikolay Popnikolov
Invasive carcinoma with a glycogen-rich clear cell pattern (IC-GRCCP) is a rare and understudied subtype of invasive breast carcinoma of no special type (IBC-NST). Here we report the molecular characteristics of a mammary IC-GRCCP diagnosed in a 69-year-old woman. Next-generation sequencing of the tumor revealed an inv(1)(p36.12,q32.1) leading to loss-of-function of ARID1A gene, a MAP2K4 truncating mutation (p.E376), MYC amplification, a variant of uncertain significance of PTPRB gene (p.D1848N) and deep deletions of NCKAP5, CCNT2, MAP3K19, LRP1B, and KMT2A. The analysis of the involved pathways shows close resemblance to the ovarian clear cell carcinoma and indicates similarities in the molecular mechanisms of development of glycogen-rich clear cell carcinomas in different organs. Our findings and the literature review suggest new potential strategies for treatment of mammary IC-GRCCP, including epigenetic therapies, checkpoint inhibitors, radiation, or other double-strand DNA breaks-inducing agents. Nevertheless, larger studies are needed to substantiate those ideas.

6 May 2025 in Cancer Cytopathology
Verified
Journal Article
Closed access
NKNikka Khorsandi
Nikka Khorsandi
PVPoonam Vohra
Poonam Vohra
PSPeyman Samghabadi
Peyman Samghabadi
CVCarlo De La Sancha Verduzco
Carlo De La Sancha Verduzco
DLDominic Lung
Dominic Lung
SLSteven R. Long
Steven R. Long